Lobbying registration dated 2026-03-11
Registrant: Richard Maksymetz
Client: Moderna Biopharma Canada Corporation
Targeted institutions:
Prairies Economic Development Canada (PrairiesCan)
Treasury Board Of Canada Secretariat (TBS)
Public Services and Procurement Canada (PSPC)
Innovation, Science and Economic Development Canada (ISED)
House of Commons
Global Affairs Canada (GAC)
Public Health Agency of Canada (PHAC)
Federal Economic Development Agency for Southern Ontario (FedDev)
Privy Council Office (PCO)
Health Canada (HC)
Government funding received:
Institution: Government of Québec (Investissement Québec)
Amount: 5629601.00
Lobbying activity details:
Communicating with government officials about procurement polices and procedures (including, but not limited to, those maintained by the Departments of Health and Public Services and Procurement), more specifically policies and procedures pertaining to the development, procurement and distribution of vaccines, including Moderna's messenger ribonucleic acid ("mRNA") vaccines.
Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology.
Communicating with government officials about pandemic and emergency planning, including the "Pandemic Preparedness Plan" being prepared by the Public Health Agency of Canada ("PHAC").
Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada, including at Moderna's facility in Laval, Québec.